
    
      Primary Objective:

      To describe the incidence and characteristics of, and change in, chronic neuropathy symptoms
      related to cisplatin, using the EORTC CIPN-20 instrument

      Procedures:

      The EORTC QLQ-CIPN20 questionnaire will be completed on day one of each cycle of
      chemotherapy, once every three weeks (+/-7 days) and once every 2 months (+/- 30 days) from
      the last dose of chemotherapy. Patients will be asked to complete the questionnaire in clinic
      during their routine visits.

      As part of this study, a DNA blood sample will be collected and stored with the Indiana
      Biobank on Day 1 of Cycle 1.
    
  